EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer.
EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer.
复制标题
DOI:
10.1038/s41467-018-05992-x
复制
发表时间:
2018-08-29
影响因子:
16.6
通讯作者:
Galsky MD
中科院分区:
文献类型:
--
作者:
Wang L;Saci A;Szabo PM;Chasalow SD;Castillo-Martin M;Domingo-Domenech J;Siefker-Radtke A;Sharma P;Sfakianos JP;Gong Y;Dominguez-Andres A;Oh WK;Mulholland D;Azrilevich A;Hu L;Cordon-Cardo C;Salmon H;Bhardwaj N;Zhu J;Galsky MD
Cancers infiltrated with T-cells are associated with a higher likelihood of response to PD-1/PD-L1 blockade. Counterintuitively, a correlation between epithelial–mesenchymal transition (EMT)-related gene expression and T-cell infiltration has been observed across tumor types. Here we demonstrate, using The Cancer Genome Atlas (TCGA) urothelial cancer dataset, that although a gene expression-based measure of infiltrating T-cell abundance and EMT-related gene expression are positively correlated, these signatures convey disparate prognostic information. We further demonstrate that non-hematopoietic stromal cells are a major source of EMT-related gene expression in bulk urothelial cancer transcriptomes. Finally, using a cohort of patients with metastatic urothelial cancer treated with a PD-1 inhibitor, nivolumab, we demonstrate that in patients with T-cell infiltrated tumors, higher EMT/stroma-related gene expression is associated with lower response rates and shorter progression-free and overall survival. Together, our findings suggest a stroma-mediated source of immune resistance in urothelial cancer and provide rationale for co-targeting PD-1 and stromal elements. Although T-cell infiltration is correlated with EMT-related gene expression in urothelial cancer specimens, here, the authors report EMT-related signatures in urothelial cancer arise mainly from stromal cells. Increased EMT-related gene expression in T-cell infiltrated tumors is associated with an attenuated response to immune checkpoint blockade, providing a rationale for therapeutic co-targeting PD-1 and stromal elements.
登录
查看更多内容
影响因子:
45.3
作者:
Massard, Christophe;Gordon, Michael S.;Segal, Neil H.
通讯作者:
Segal, Neil H.
DOI:
10.1158/1078-0432.ccr-15-1434
发表时间:
2016-07-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Lou Y;Diao L;Cuentas ER;Denning WL;Chen L;Fan YH;Byers LA;Wang J;Papadimitrakopoulou VA;Behrens C;Rodriguez JC;Hwu P;Wistuba II;Heymach JV;Gibbons DL
通讯作者:
Gibbons DL
影响因子:
64.5
作者:
Hugo W;Zaretsky JM;Sun L;Song C;Moreno BH;Hu-Lieskovan S;Berent-Maoz B;Pang J;Chmielowski B;Cherry G;Seja E;Lomeli S;Kong X;Kelley MC;Sosman JA;Johnson DB;Ribas A;Lo RS
通讯作者:
Lo RS
影响因子:
64.8
作者:
Herbst RS;Soria JC;Kowanetz M;Fine GD;Hamid O;Gordon MS;Sosman JA;McDermott DF;Powderly JD;Gettinger SN;Kohrt HE;Horn L;Lawrence DP;Rost S;Leabman M;Xiao Y;Mokatrin A;Koeppen H;Hegde PS;Mellman I;Chen DS;Hodi FS
通讯作者:
Hodi FS
影响因子:
5.8
作者:
Gaujoux, Renaud;Seoighe, Cathal
通讯作者:
Seoighe, Cathal